Home › Compare › MLCOF vs MRK

MLCOF vs MRK: Dividend Comparison 2026

MLCOF yields 90909.09% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MLCOF wins by $1.8657767678438335e+26M in total portfolio value
10 years
MLCOF
MLCOF
● Live price
90909.09%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.8657767678438335e+26M
Annual income
$186,174,819,330,989,220,000,000,000,000,000.00
Full MLCOF calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — MLCOF vs MRK

📍 MLCOF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMLCOFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MLCOF + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
MLCOF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MLCOF
Annual income on $10K today (after 15% tax)
$7,727,272.73/yr
After 10yr DRIP, annual income (after tax)
$158,248,596,431,340,840,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, MLCOF beats the other by $158,248,596,431,340,840,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MLCOF + MRK for your $10,000?

MLCOF: 50%MRK: 50%
100% MRK50/50100% MLCOF
Portfolio after 10yr
$9.328883839219167e+25M
Annual income
$93,087,409,665,494,610,000,000,000,000,000.00/yr
Blended yield
99.78%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

MLCOF
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MLCOF buys
0
MRK buys
0
No recent congressional trades found for MLCOF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMLCOFMRK
Forward yield90909.09% ✓3.25%
Annual dividend / share$2.00$3.08 ✓
Payout ratio50%42% ✓
1-year div growth0%5.5% ✓
5-year div CAGR0%8.2% ✓
Portfolio after 10y$1.8657767678438335e+26M$30.7K ✓
Annual income after 10y$186,174,819,330,989,220,000,000,000,000,000.00 ✓$950.29
Total dividends collected$1.865512718252454e+26M$6.1K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MLCOF vs MRK ($10,000, DRIP)

YearMLCOF PortfolioMLCOF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$9,101,609$9,090,909.09$11,192$351.54+$9.09M → MLCOF
2$7,742,626,649$7,732,887,927.71$12,524$392.70+$7742.61M → MLCOF
3$6,156,202,768,855$6,147,918,158,340.57$14,015$438.65+$6156202.75M → MLCOF
4$4,575,037,364,168,400$4,568,450,227,205,725.00$15,682$489.96+$4575037364.15M → MLCOF
5$3,177,871,744,582,025,000$3,172,976,454,602,365,000.00$17,547$547.23+$3177871744582.01M → MLCOF
6$2,063,199,081,001,827,700,000$2,059,798,758,235,125,000,000.00$19,632$611.16+$2063199081001827.75M → MLCOF
7$1,252,022,771,935,710,300,000,000$1,249,815,148,919,038,400,000,000.00$21,963$682.53+$1252022771935710208.00M → MLCOF
8$710,154,989,871,965,200,000,000,000$708,815,325,505,994,000,000,000,000.00$24,571$762.18+$710154989871965274112.00M → MLCOF
9$376,502,292,891,686,800,000,000,000,000$375,742,427,052,523,800,000,000,000,000.00$27,486$851.08+$3.7650229289168676e+23M → MLCOF
10$186,577,676,784,383,340,000,000,000,000,000$186,174,819,330,989,220,000,000,000,000,000.00$30,745$950.29+$1.8657767678438335e+26M → MLCOF

MLCOF vs MRK: Complete Analysis 2026

MLCOF — Stock

Melco China Resorts (Holding) Limited develops and operates ski resorts in China. Its portfolio includes Sun Mountain Yabuli, Sky Mountain Beidahu, The Lotus Mountain Club, Adventure Mountain Changchun, and Star Mountain Beijing resort properties in Beijing, Heilongjiang Province, and Jilin Province. The company offers a range of accommodations, including full-service hotels, condominium-hotels, and luxury resort homes. Melco China Resorts (Holding) Limited is based in Beijing, China.

Full MLCOF Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this MLCOF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MLCOF vs SCHDMLCOF vs JEPIMLCOF vs OMLCOF vs KOMLCOF vs MAINMLCOF vs JNJMLCOF vs ABBVMLCOF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.